NiSource Inc. (NI) stock
Close on Oct 30, 2026Market cap $21.37BP/E 23.6Yield 2.51%
Earnings
NiSource's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of NiSource's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 10, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026before the open | – | – | $0.27 | $0.27 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026before the open | – | – | $0.09 | $0.16 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026before the open | – | – | $1.06 | $1.06 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 11, 2026before the open | – | – | $0.53 | $0.51 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 29, 2025before the open | -$4.00M | – | $0.20 | $0.19 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025before the open | – | – | $0.22 | $0.22 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 7, 2025before the open | – | – | $1.00 | $0.98 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 12, 2025before the open | – | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 30, 2024before the open | – | – | $0.19 | $0.20 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024before the open | – | – | $0.19 | $0.21 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024before the open | – | – | $0.77 | $0.85 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 21, 2024before the open | – | – | $0.50 | $0.53 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 1, 2023before the open | – | – | $0.17 | $0.19 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 2, 2023before the open | – | – | $0.09 | $0.11 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023before the open | – | – | $0.71 | $0.77 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023before the open | – | – | $0.52 | $0.50 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022before the open | – | – | $0.12 | $0.10 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022before the open | – | – | $0.12 | $0.12 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022before the open | – | – | $0.94 | $0.75 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 23, 2022before the open | – | – | $0.36 | $0.39 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021before the open | – | – | $0.12 | $0.11 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 17, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 2, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
NiSource's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| non-GAAP consolidated adjusted EPSnon-GAAP | FY2026 | $2.02 – $2.07 | – | New | Oct 28, 2026 |
| non‑GAAP consolidated adjusted EPSnon-GAAP | FY2026 | $2.02 – $2.07 | $2.02 – $2.07 | Reaffirmed | Aug 5, 2026 |
| Annual non-GAAP NOEPS growthnon-GAAP | FY2027 | +6% – +8% | +6% – +8% | Reaffirmed | Aug 2, 2023 |
| non-GAAP consolidated adjusted EPSnon-GAAP | FY2027 | $2.22 – $2.30 | – | New | Oct 28, 2026 |
| adjusted EPS growthnon-GAAP | FY2029 | +6% – +8% | – | New | Oct 30, 2024 |
Guidance vs results
The last range NiSource gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | non-GAAP adjusted EPS guidance | $1.85 – $1.89 | $1.90Σ4Q | Above range |
Guidance history
Every forecast NiSource put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | consolidated seven-year total capital expenditures | 2027-2033 | $40.00B | – |
| Oct 28, 2026 | non-GAAP consolidated adjusted EPS | FY2026 | $2.02 – $2.07 | New |
| Oct 28, 2026 | non-GAAP consolidated adjusted EPS | FY2027 | $2.22 – $2.30 | New |
| Oct 28, 2026 | consolidated non-GAAP adjusted EPS compound annual growth rate (CAGR) | 2027-2033 | +10% – +11% | – |
| Oct 28, 2026 | base plan non-GAAP adjusted EPS growth | annually | +6% – +8% | – |
| Oct 28, 2026 | consolidated investment base growth | 2027-2033 | +9% – +10% | – |
| Oct 28, 2026 | rate base growth | 2027-2033 | +8% – +10% | – |
| Aug 5, 2026 | consolidated capital investment plan | 2026-2030 | $28.60B | – |
| Aug 5, 2026 | non-GAAP consolidated adjusted EPS compound annual growth rate (CAGR) | 2026-2033 | +9% – +10% | – |
| Aug 5, 2026 | non‑GAAP consolidated adjusted EPS | FY2026 | $2.02 – $2.07 | Reaffirmed |
| Aug 5, 2026 | consolidated rate base growth | 2026-2033 | +9% – +11% | – |
| May 6, 2026 | non‑GAAP consolidated adjusted EPS | FY2026 | $2.02 – $2.07 | Reaffirmed |
| May 6, 2026 | consolidated compound annual growth rate (CAGR) with respect to non‑GAAP consolidated adjusted EPS | 2026 through 2033 | +9% – +10% | – |
| Feb 11, 2026 | consolidated capital plan | 2026–2030 | $28.00B | – |
| Feb 11, 2026 | non‑GAAP consolidated adjusted EPS | FY2026 | $2.02 – $2.07 | Reaffirmed |
| Feb 11, 2026 | non‑GAAP consolidated adjusted EPS compound annual growth rate | 2026 through 2033 | +8% – +9% | – |
| Feb 11, 2026 | consolidated rate base growth | 2026 through 2033 | +9% – +11% | – |
| Oct 29, 2025 | consolidated capital expenditure plan | five-year plan | $28.00B | – |
| Oct 29, 2025 | base plan capital expenditures | 2026 to 2030 | $21.00B | – |
| Oct 29, 2025 | base plan non-GAAP adjusted EPS growth | 2026 to 2030 | +6% – +8% | – |
| Oct 29, 2025 | consolidated non-GAAP adjusted EPS compound annual growth rate (CAGR) | 2026 through 2033 | +8% – +9% | – |
| Oct 29, 2025 | non-GAAP adjusted EPS guidance | FY2025 | $1.85 – $1.89 | Reaffirmed |
| Oct 29, 2025 | non-GAAP consolidated adjusted EPS | FY2026 | $2.02 – $2.07 | New |
| Aug 6, 2025 | capital expenditures | 2025-2029 period | $19.40B | – |
| Aug 6, 2025 | non-GAAP adjusted EPS guidance | FY2025 | $1.85 – $1.89 | New |
| Aug 6, 2025 | non-GAAP adjusted EPS growth | 2025-2029 | +6% – +8% | – |
| Aug 6, 2025 | Annual rate base growth | 2025-2029 | +8% – +10% | – |
| May 7, 2025 | non-GAAP adjusted EPS guidance | FY2025 | $1.85 – $1.89 | Reaffirmed |
| May 7, 2025 | non-GAAP adjusted EPS growth | 2025-2029 period | +6% – +8% | – |
| May 7, 2025 | rate base growth | 2025-2029 period | +8% – +10% | – |
| Feb 12, 2025 | base capital expenditure plan | 2025-2029 | $19.40B | – |
| Feb 12, 2025 | non-GAAP adjusted EPS growth | 2025-2029 period | +6% – +8% | – |
| Feb 12, 2025 | non-GAAP adjusted EPS | FY2025 | $1.85 – $1.89 | Raised |
| Feb 12, 2025 | rate base growth | 2025-2029 period | +8% – +10% | – |
| Oct 30, 2024 | base plan capital expenditures | 2025-2029 | $19.30B | – |
| Oct 30, 2024 | adjusted EPS guidance | FY2024 | $1.70 – $1.74 | Reaffirmed |
| Oct 30, 2024 | adjusted EPS | FY2025 | $1.84 – $1.88 | New |
| Oct 30, 2024 | adjusted EPS growth | FY2029 | +6% – +8% | New |
| Oct 30, 2024 | rate base growth | 2025-2029 | +8% – +10% | – |
| Aug 7, 2024 | base capital expenditure plan | 2024-2028 | $16.40B | – |
| Aug 7, 2024 | annual adjusted EPS growth | 2023-2028 period | +6% – +8% | – |
| Aug 7, 2024 | adjusted EPS | FY2024 | $1.70 – $1.74 | Reaffirmed |
| Aug 7, 2024 | annual rate base growth | 2023-2028 period | +8% – +10% | – |
| May 8, 2024 | base capital expenditure plan | 2024-2028 | $16.40B | – |
| May 8, 2024 | adjusted EPS | FY2024 | $1.70 – $1.74 | Reaffirmed |
| May 8, 2024 | annual adjusted EPS growth | 2023-2028 period | +6% – +8% | – |
| May 8, 2024 | annual rate base growth | 2023-2028 period | +8% – +10% | – |
| Feb 21, 2024 | base capital expenditure plan | 5-year | $16.00B | – |
| Feb 21, 2024 | annual non-GAAP NOEPS growth | 2023-2028 | +6% – +8% | – |
| Feb 21, 2024 | non-GAAP NOEPS | FY2024 | $1.70 – $1.74 | Raised |
| Feb 21, 2024 | annual rate base growth | 2023-2028 | +8% – +10% | – |
| Nov 1, 2023 | base plan capital expenditures | 2024-28 | $16.00B | – |
| Nov 1, 2023 | non-GAAP NOEPS | FY2023 | $1.54 – $1.60 | Reaffirmed |
| Nov 1, 2023 | non-GAAP NOEPS | FY2024 | $1.68 – $1.72 | New |
| Nov 1, 2023 | non-GAAP NOEPS growth | 2023-28 | +6% – +8% | – |
| Nov 1, 2023 | rate base growth | 2023-28 | +8% – +10% | – |
| Aug 2, 2023 | capital expenditures | 2023-27 period | $15.00B | – |
| Aug 2, 2023 | Annual non-GAAP NOEPS growth | FY2027 | +6% – +8% | Reaffirmed |
| Aug 2, 2023 | non-GAAP NOEPS | FY2023 | $1.54 – $1.60 | Reaffirmed |
| Aug 2, 2023 | Annual rate base growth | 2023-27 | +8% – +10% | – |
| May 3, 2023 | capital expenditures | 2023-27 period | $15.00B | – |
| May 3, 2023 | non-GAAP NOEPS | FY2023 | $1.54 – $1.60 | Reaffirmed |
| May 3, 2023 | growth | FY2027 | +6% – +8% | Reaffirmed |
| May 3, 2023 | Annual rate base growth | 2023-27 period | +8% – +10% | – |
| Feb 22, 2023 | non-GAAP NOEPS | FY2023 | $1.54 – $1.60 | Raised |
| Feb 22, 2023 | annual non-GAAP NOEPS growth | FY2027 | +6% – +8% | New |
| Nov 7, 2022 | non-GAAP diluted net operating earnings per share (NOEPS) | FY2022 | $1.44 – $1.46 | Narrowed |
| Nov 7, 2022 | non-GAAP diluted NOEPS | FY2023 | $1.50 – $1.57 | New |
| Aug 3, 2022 | near-term annual growth | FY2023 | +5% – +7% | Reaffirmed |
| Aug 3, 2022 | non-GAAP diluted NOEPS | FY2024 | +7% – +9% | Reaffirmed |
| Aug 3, 2022 | non-GAAP diluted net operating earnings per share (NOEPS) | FY2022 | $1.42 – $1.48 | Reaffirmed |
| May 4, 2022 | non-GAAP diluted net operating earnings per share (NOEPS) | FY2022 | $1.42 – $1.48 | Reaffirmed |
| May 4, 2022 | near-term annual growth | FY2023 | +5% – +7% | Reaffirmed |
| May 4, 2022 | non-GAAP diluted NOEPS | FY2024 | +7% – +9% | Reaffirmed |
| Feb 23, 2022 | Non-GAAP diluted net operating earnings per share (NOEPS) | FY2024 | +7% – +9% | Reaffirmed |
| Feb 23, 2022 | non-GAAP diluted net operating EPS | FY2022 | $1.42 – $1.48 | Reaffirmed |
| Feb 23, 2022 | near-term annual growth | FY2023 | +5% – +7% | Reaffirmed |
| Feb 23, 2022 | compound annual rate base growth | FY2024 | +10% – +12% | Reaffirmed |
| Nov 3, 2021 | capital investments | FY2021 | $2.00B | New |
| Nov 3, 2021 | capital investments | FY2022 | $2.40B – $2.70B | New |
| Nov 3, 2021 | capital investments | 2021-2024 | $10.00B | – |
| Nov 3, 2021 | non-GAAP diluted net operating EPS | FY2022 | $1.42 – $1.48 | New |
| Nov 3, 2021 | near-term annual growth | FY2023 | +5% – +7% | New |
| Nov 3, 2021 | Non-GAAP diluted net operating earnings per share (NOEPS) | FY2024 | +7% – +9% | New |
| Nov 3, 2021 | non-GAAP diluted net operating earnings | FY2021 | $1.32 – $1.36 | New |
| Nov 3, 2021 | compound annual rate base growth | FY2024 | +10% – +12% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases NiSource filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- Results
- News